<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>GIDS Research Radar · Chronic hepatitis B</title>
  <link>https://globalinfectiousdisease.com/research/</link>
  <description>Published infectious-disease literature filtered to Chronic hepatitis B.</description>
  <language>en</language>
  <atom:link href="https://globalinfectiousdisease.com/research/rss/diseases/chronic-hepatitis-b.xml" rel="self" type="application/rss+xml" />
  <lastBuildDate>Wed, 09 Sep 2026 07:02:01 GMT</lastBuildDate>
  <item>
    <title>Functionally cured chronic hepatitis B: A cure‐related occult HBV infection state</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1002-mlf2-70102-c24dd73a/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1002-mlf2-70102-c24dd73a/</guid>
    <pubDate>Thu, 27 Aug 2026 00:00:00 GMT</pubDate>
    <description>Maintaining blood supply integrity and establishing standardized post-treatment monitoring pathways are essential to address residual transmissibility in clinically resolved cases.</description>
    <category>Hepatitis D</category>
    <category>Hepatitis B</category>
    <category>Chronic hepatitis B</category>
    <category>Transmission dynamics</category>
    <category>Diagnostics</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Pradefovir mesylate and tenofovir amibufenamide for chronic hepatitis B: a systematic review and pragmatic treatment algorithm</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3389-fphar-2026-1862886-7d080baa/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3389-fphar-2026-1862886-7d080baa/</guid>
    <pubDate>Mon, 24 Aug 2026 00:00:00 GMT</pubDate>
    <description>The manuscript consolidates comparative safety and efficacy data to inform clinical guidelines regarding newly approved nucleotide prodrugs for chronic hepatitis B management.</description>
    <category>Hepatitis B</category>
    <category>Chronic hepatitis B</category>
    <category>Hepatitis D</category>
    <category>Treatment</category>
    <category>Health policy</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>HBsAg glycan isomer: a potential circulating biomarker for monitoring cccDNA and predicting virologic response in chronic hepatitis B</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3389-fcimb-2026-1818958-aa058eb2/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3389-fcimb-2026-1818958-aa058eb2/</guid>
    <pubDate>Thu, 20 Aug 2026 00:00:00 GMT</pubDate>
    <description>If validated, HBsAgGi could offer a minimally invasive serum indicator of intrahepatic cccDNA activity and a tool for monitoring antiviral response in chronic hepatitis B, which is relevant to treatment management in affected populations.</description>
    <category>Hepatitis B</category>
    <category>Chronic hepatitis B</category>
    <category>Hepatitis D</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Africa’s Silent Humanitarian Crisis: Why Viral Hepatitis Must No Longer Be Ignored</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1093-rescon-vmag135-8768e99e/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1093-rescon-vmag135-8768e99e/</guid>
    <pubDate>Mon, 17 Aug 2026 00:00:00 GMT</pubDate>
    <description>The article positions viral hepatitis as an urgent public health priority warranting immediate action through expanded testing, diagnosis, treatment, birth-dose vaccination, and integration with Universal Health Coverage initiatives.</description>
    <category>Viral Hepatitis</category>
    <category>Malaria</category>
    <category>Chronic hepatitis B</category>
    <category>Tuberculosis</category>
    <category>Hepatitis B</category>
    <category>Hepatitis C</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Hepatic Artery Doppler Haemodynamic Indices as Imaging Biomarkers of Disease Activity in Adults with Chronic Hepatitis B: Correlation with Viral Load and Serum Alanine Transaminase</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-4103-npmj-npmj-141-26-d8b6a40c/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-4103-npmj-npmj-141-26-d8b6a40c/</guid>
    <pubDate>Mon, 17 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings support further consideration of hepatic artery Doppler measurements as non-invasive markers of hepatic vascular changes or disease-related laboratory abnormalities in asymptomatic adults with chronic hepatitis B. The supplied article does not establish effects on patient outcomes, transmission, or population-level disease control.</description>
    <category>Hepatitis B</category>
    <category>Chronic hepatitis B</category>
    <category>Hepatitis D</category>
    <category>Treatment</category>
    <category>Cross-sectional study</category>
  </item>
  <item>
    <title>Restoration of a functional antiviral immune response to chronic HBV infection by reducing viral antigen load: if not sufficient, is it necessary?</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1080-22221751-2021-1952851-82959ab5/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1080-22221751-2021-1952851-82959ab5/</guid>
    <pubDate>Sat, 07 Aug 2021 00:00:00 GMT</pubDate>
    <description>Discussions focus on developing therapies to achieve durable control of the infection, described as a functional cure, for most treated patients.</description>
    <category>Hepatitis B</category>
    <category>Hepatitis D</category>
    <category>Chronic hepatitis B</category>
    <category>Treatment</category>
    <category>Vaccination</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Prevention of Chronic Hepatitis B after 3 Decades of Escalating Vaccination Policy, China</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3201-eid2305-161477-d21f5459/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3201-eid2305-161477-d21f5459/</guid>
    <pubDate>Mon, 01 May 2017 00:00:00 GMT</pubDate>
    <description>China&apos;s perinatal transmission-targeted HBV prevention program has been highly successful and increasingly effective. Sustained effort over decades and augmented strategies will be needed to eliminate HBV transmission.</description>
    <category>Hepatitis B</category>
    <category>Hepatitis D</category>
    <category>Hepatitis C</category>
    <category>Hepatitis E</category>
    <category>Chronic hepatitis B</category>
    <category>Surveillance</category>
    <category>Vaccination</category>
    <category>Health policy</category>
    <category>Transmission dynamics</category>
    <category>Journal article</category>
  </item>
</channel>
</rss>
